Cargando…
771 Enzymatic Burn Wound Debridement: The Learning Curve
INTRODUCTION: The European Medicines Agency (MEA) approved the use of a proteolytic enzymatic debriding agent enriched in bromelain in 2012. It has become a widely used non-surgical treatment alternative for the debridement of deep partial thickness to full thickness thermal burns. We will present o...
Autores principales: | Mertz, Tamara, Sen, Sankhya, Mackie, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185165/ http://dx.doi.org/10.1093/jbcr/irad045.246 |
Ejemplares similares
-
769 Racial, Ethnic, and Socioeconomic Disparities in Burn Care Access
por: Tomtschik, Julia, et al.
Publicado: (2023) -
773 Inhalation Injury Severity Score on Admission Predicts Overall Survival in Burn ICU Patients
por: Flinn, Ashley, et al.
Publicado: (2023) -
772 Bismuth Tribromophenate Gauze is Superior to Silver Sulfadiazine Cream for Mixed-depth Scald Burns in Children
por: Alessio-Bilowus, Dominic, et al.
Publicado: (2023) -
601 Bromelain Based Enzymatic Debridement Followed by Application of Autologous Cell Suspension for Treatment of Burns
por: Williams, Ashley, et al.
Publicado: (2022) -
770 Outcome Results of the Prospective CEA Registry
por: Homsombath, Bounthavy, et al.
Publicado: (2023)